SCHEMBL9684884

SCHEMBL9684884

CC(=O)OCCCc1cc(/C=C2\SCNC2=O)cc(CCCOC(C)=O)c1O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TNKS2 Q9H2K2 1/20 0.39
IGF1R P08069 3/20 0.34
NAT1 P18440 2/20 0.33
CISD1 Q9NZ45 2/20 0.33
PTPN1 P18031 1/20 0.33
CDC25B P30305 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C9 P11712 1/20 0.33
MEN1 O00255 1/20 0.32
NPC1 O15118 1/20 0.32
ALDH1A1 P00352 1/20 0.32
LMNA P02545 1/20 0.32
POLB P06746 1/20 0.32
GAA P10253 1/20 0.32
MAPT P10636 1/20 0.32
KMT2A Q03164 1/20 0.32
PTGS2 P35354 5/20 0.32
PTGS1 P23219 1/20 0.32
CTSD P07339 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9684891 1.00 TNKS2 (0.39) TNKS2IGF1RNAT1CISD1PTPN1
SCHEMBL8534279 0.81 CYP1A2 (0.41) IGF1RNAT1CISD1CYP1A2CYP3A4
SCHEMBL8896050 0.79 TNKS2 (0.38) TNKS2NAT1CYP1A2CYP3A4CYP2C9
SCHEMBL8893765 0.77 TNKS2 (0.36) TNKS2CYP1A2CYP3A4CYP2C9ALDH1A1
SCHEMBL8894717 0.74 NAT1 (0.56) NAT1CISD1MEN1MAPTKMT2A
SCHEMBL9027978 0.74 NAT1 (0.56) NAT1CISD1MEN1MAPTKMT2A
SCHEMBL8535042 0.73 MEN1 (0.43) IGF1RNAT1CISD1PTPN1CDC25B
SCHEMBL3263476 0.68 PTGS2 (0.64) CYP1A2CYP2C9GAAPTGS2PTGS1
SCHEMBL28499090 0.65 TNKS2 (0.46) TNKS2CYP3A4ALDH1A1MAOA
SCHEMBL8536501 0.65 PTGS2 (0.55) CYP1A2CYP2C9MEN1NPC1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0500337-A1 Composition containing aryl-substituted rhodanine derivatives for the treatment of type I diabetes UNIVERSITY OF COLORADO FOUNDATION, INC. (US) 1992-08-26 EP disclosed